Yahoo Suche Web Suche

  1. Many women made pioneering scientific breakthroughs over the past centuries. Learn about famous women scientists who have changed our understanding of the world.

  2. Über 7 Millionen englischsprachige Bücher. Jetzt versandkostenfrei bestellen!

Suchergebnisse

  1. Suchergebnisse:
  1. Vor 5 Tagen · 28 May 2024. A teenager whose cancer symptoms were initially put down to "growing pains" has urged young people to "be persistent" with their doctors. Alessia, who was eventually diagnosed with ...

  2. Vor 4 Tagen · lymphoma, any of a group of malignant diseases of the lymphatic system, usually starting in the lymph nodes or in lymphoid tissues of other organs, such as the lungs, spleen, and skin. Lymphomas are generally classified into two types, Hodgkin disease and non-Hodgkin lymphoma. Hodgkin disease results in enlargement of the lymph nodes and spleen.

    • The Editors of Encyclopaedia Britannica
  3. Vor 3 Tagen · Dorothy Crowfoot Hodgkin Konrad Emil Bloch Feodor F. K. Lynen: 1963 Eugene Wigner Maria Goeppert-Mayer J. Hans D. Jensen Karl Ziegler Giulio Natta Sir John Carew Eccles Sir Alan Lloyd Hodgkin Sir Andrew Fielding Huxley: 1962 Lev Davidovich Landau

  4. Vor 3 Tagen · The missing heiress at the center of New York’s oldest cold case. For the first time in more than a century, the family of Dorothy Arnold breaks silence to reveal new insights.

  5. Vor 3 Tagen · Grants and Finance Manager. Dorothy Crowfoot Hodgkin Building, Biochemistry Department, South Parks Road, Oxford, OX1 3QU. Grants and Finance Manager. Department of Biochemistry. Pay Scale: STANDARD GRADE 8. Salary (£): £45,585-£54,395 per annum.

  6. Vor 2 Tagen · Recipient of the 1964 Nobel Prize in Chemistry, Dorothy Crowfoot Hodgkin revolutionized the field of medicine by discovering the structure of penicillin, vitamin B12, and insulin. Her...

  7. Vor 3 Tagen · Hodgkin-Lymphome: Reduktion von eBEACOPP-Zyklen bei Patienten mit schnellem metabolischen Ansprechen. Reduktion von eBEACOPP-Therapiezyklen möglich - EHA 2017. Patienten mit fortgeschrittenen Hodgkin-Lymphomen müssen sich in der Regel einer intensiven Therapie nach dem eBEACOPP-Schema unterziehen.